A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/726 (2006.01) A61K 9/00 (2006.01) A61K 9/12 (2006.01) A61K 9/72 (2006.01) A61K 31/727 (2006.01) A61K 31/728 (2006.01) A61K 31/737 (2006.01) A61P 11/00 (2006.01) A61P 11/12 (2006.01) A61P 31/00 (2006.01) A61K 38/46 (2006.01)
Patent
CA 2516318
A glycosaminoglycan or a physiologically acceptable salt thereof, which has an average molecule weight of from 8 to 40 kd can be used to treat chronic airflow limitation (CAL). The glycosaminoglycan or salt is typically inhaled.
La présente invention concerne un glycosaminoglycane ou un sel pharmaceutiquement acceptable de ce dernier, qui possède un poids moléculaire moyen compris entre 8 et 40 kD, qui peut être utilisé pour traiter les limitations chroniques du passage de l'air. Le glycosaminoglycane de l'invention ou son sel est généralement inhalé.
Carroll Mary Patricia
Conway Joy Helen
Hockey Peter Morey
Shute Janis Kay
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
University Of Southampton
LandOfFree
Use of glycosaminoglycans such as heparin for the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of glycosaminoglycans such as heparin for the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of glycosaminoglycans such as heparin for the treatment... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2063769